United Capital Financial Advisors LLC Takes Position in Corteva, Inc. $CTVA

United Capital Financial Advisors LLC purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 43,210 shares of the company’s stock, valued at approximately $3,659,000.

A number of other hedge funds have also bought and sold shares of CTVA. BlackRock Inc. bought a new stake in shares of Corteva during the 2nd quarter worth $4,560,180,000. Harris Associates L P increased its holdings in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after buying an additional 10,675,052 shares during the last quarter. Norges Bank bought a new stake in Corteva in the fourth quarter worth about $504,001,000. Jupiter Topco LLC bought a new stake in Corteva in the second quarter worth about $544,246,000. Finally, Bank of America Corp DE purchased a new position in Corteva in the second quarter valued at about $484,927,000. 81.54% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CTVA has been the topic of a number of research reports. Oppenheimer lifted their price target on shares of Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, July 23rd. Bank of America increased their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. CICC Research raised their target price on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Finally, Citigroup upped their price target on Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus target price of $91.50.

Corteva Stock Up 1.9%

CTVA opened at $84.00 on Friday. The company has a 50 day moving average of $82.69 and a 200 day moving average of $80.54. The company has a market cap of $56.04 billion, a PE ratio of 55.63, a price-to-earnings-growth ratio of 2.53 and a beta of 0.57. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 47.68%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.